Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health Nationwide (Federal)
Tell us about your organization and we'll show you whether this grant fits, and why.
Free to start. No credit card required.
Deadline
May 7, 2028
Region
Nationwide (Federal)
Funder type
Federal Government
For
Nonprofits & businesses
Sectors
Health & Human Services
About this program
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) — U.S. federal funding opportunity (PAR-25-374) from National Institutes of Health. See grants.gov for full eligibility and details.
Is this grant worth your time?
Create a free account and Happy Grants scores this program, and 2,300+ others, against your organization’s profile in about a minute, with the reasons explained.
See your match score, freeSimilar grants
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)National Institutes of Health Jul 7, 2028
- BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)National Institutes of Health Feb 8, 2029
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)National Institutes of Health Jan 7, 2028
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)National Institutes of Health Jan 7, 2028
- Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)National Institutes of Health Jan 28, 2028
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)National Institutes of Health May 4, 2028